Davene R Wright1, S Bryn Austin, H LeAnn Noh, Yushan Jiang, Kendrin R Sonneville. 1. Davene R. Wright is with the Department of Pediatrics, University of Washington School of Medicine, and the Center for Child Health, Behavior, and Development, Seattle Children's Research Institute, Seattle. S. Bryn Austin is with the Department of Social and Behavioral Sciences, Harvard School of Public Health, and the Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, Boston. Kendrin R. Sonneville is with the Department of Pediatrics, Harvard Medical School, and the Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, Boston. H. LeAnn Noh is with the Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston. Yushan Jiang is with the Department of Global Health and Population, Harvard School of Public Health, Boston.
Abstract
OBJECTIVES: We aimed to assess the value of school-based eating disorder (ED) screening for a hypothetical cohort of US public school students. METHODS: We used a decision-analytic microsimulation model to model the effectiveness (life-years with ED and quality-adjusted life-years [QALYs]), total direct costs, and cost-effectiveness (cost per QALY gained) of screening relative to current practice. RESULTS: The screening strategy cost $2260 (95% confidence interval [CI] = $1892, $2668) per student and resulted in a per capita gain of 0.25 fewer life-years with ED (95% CI = 0.21, 0.30) and 0.04 QALYs (95% CI = 0.03, 0.05) relative to current practice. The base case cost-effectiveness of the intervention was $9041 per life-year with ED avoided (95% CI = $6617, $12,344) and $56,500 per QALY gained (95% CI = $38,805, $71,250). CONCLUSIONS: At willingness-to-pay thresholds of $50,000 and $100,000 per QALY gained, school-based ED screening is 41% and 100% likely to be cost-effective, respectively. The cost-effectiveness of ED screening is comparable to many other accepted pediatric health interventions, including hypertension screening.
OBJECTIVES: We aimed to assess the value of school-based eating disorder (ED) screening for a hypothetical cohort of US public school students. METHODS: We used a decision-analytic microsimulation model to model the effectiveness (life-years with ED and quality-adjusted life-years [QALYs]), total direct costs, and cost-effectiveness (cost per QALY gained) of screening relative to current practice. RESULTS: The screening strategy cost $2260 (95% confidence interval [CI] = $1892, $2668) per student and resulted in a per capita gain of 0.25 fewer life-years with ED (95% CI = 0.21, 0.30) and 0.04 QALYs (95% CI = 0.03, 0.05) relative to current practice. The base case cost-effectiveness of the intervention was $9041 per life-year with ED avoided (95% CI = $6617, $12,344) and $56,500 per QALY gained (95% CI = $38,805, $71,250). CONCLUSIONS: At willingness-to-pay thresholds of $50,000 and $100,000 per QALY gained, school-based ED screening is 41% and 100% likely to be cost-effective, respectively. The cost-effectiveness of ED screening is comparable to many other accepted pediatric health interventions, including hypertension screening.
Authors: Michelle A Scott; Holly C Wilcox; Irvin Sam Schonfeld; Mark Davies; Roger C Hicks; J Blake Turner; David Shaffer Journal: Am J Public Health Date: 2008-12-04 Impact factor: 9.308
Authors: Carlos M Grilo; Maria E Pagano; Andrew E Skodol; Charles A Sanislow; Thomas H McGlashan; John G Gunderson; Robert L Stout Journal: J Clin Psychiatry Date: 2007-05 Impact factor: 4.384
Authors: Karin S Walsh; Robert B Noll; Robert D Annett; Sunita K Patel; Andrea F Patenaude; Leanne Embry Journal: Pediatr Blood Cancer Date: 2015-10-09 Impact factor: 3.167
Authors: Anne Berghöfer; Sabrina Hense; Thomas Birker; Torsten Hejnal; Frank Röwenstrunk; Marion Albrecht; Daniela Erdmann; Thomas Reinhold; Barbara Stöckigt Journal: Front Psychiatry Date: 2020-02-12 Impact factor: 4.157